SAN JOSE, Calif. - Anixa Biosciences, Inc. (NASDAQ: NASDAQ:ANIX), a clinical-stage biotechnology company valued at $77.6 million, recently shared updates on its cancer treatment programs, including ...
Man’s best friend has taken on a remarkable new role in the fight against cancer. Thanks to a groundbreaking collaboration between canine olfactory abilities and advanced artificial intelligence (AI), ...